Navigation Links
Do Jerusalem's Arabs and Jews receive a different quality of medical care?
Date:1/25/2008

Researchers Amit Tirosh, Bmed, Ronit Calderon-Margalit, MD, MPH, Marianna Mazar, MD and Zvi Stern, MD compared the quality of care delivered to Jewish and Arab diabetes sufferers who were admitted to four major hospital emergency rooms in Jerusalem, to evaluate whether differences existed between the two groups and, if they did, their causes, given the common basis of health insurance coverage. The researchers found significant differences. As compared to the Jewish patients, Arab patients received:

  • less diet counseling
  • fewer recommendations and less support for physical activity
  • less guidance in performing self foot examinations
  • fewer medications prescribed

Quality of care of Arab patients with diabetes is lower than that received by Jewish patients in the city, write the authors in the article. Resources should be invested in early detection of diabetes among the Arab population and in intensive treatment following diagnosis, together with lifestyle modifications to improve the quality of life among Arab patients with diabetes and to decrease the economic burden of the disease.


'/>"/>

Contact: Andrea Rulfo
media.inquiries@sagepub.com
805-410-7150
SAGE Publications
Source:Eurekalert

Page: 1

Related medicine news :

1. Eleven Florida Nonprofit Organizations to Receive Grants Totaling Nearly $1 Million From The Blue Foundation
2. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
3. Siemens Receives FDA 510(K) Clearance for Next Generation Radiation Therapy Solution
4. ImmunoVaccine Technologies Receives $3 Million From ACOA
5. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
6. Students Pursuing Health Care Careers Receive $24,000 in Scholarships From National Hispanic Health Foundation
7. Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
8. MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS
9. Researcher, magnet lab receive $2 million grant to target tuberculosis
10. Novadaqs SPY System receives clearance for use in organ transplant surgery
11. Philadelphia Policeman Helps Amputee Receive Power Wheelchair from The Scooter Store
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, N.Y., ... for adherence to the highest standards of trauma, maternity, cancer and chronic obstructive ... president and CEO, Dr. Daniel Messina. , Among the recognitions, the American College ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
(Date:12/8/2016)... Rock, AR (PRWEB) , ... December 08, 2016 ... ... providing insurance and financial planning services from offices headquartered in Little Rock, has ... Food Pantry. , According to the National Foundation to End Senior Hunger, Arkansas ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an ... around the greater Phoenix metropolitan region, is announcing a charity event to provide ... the Homeless Youth Connection is to promote community awareness of the ongoing needs ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey ... to residential and commercial clients in the northern Alabama and Georgia regions, is ... , Since 1977, Nobis Works has built a network of support and education ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016   TriNetX , ... Nationwide Children,s Hospital signed a membership agreement ... the development of new cures. The ... over 57 million patients globally, biopharmaceutical companies and ... to improve protocol design, site selection, patient recruitment, ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: